ImmunologybioRxiv
Ad26-vector based COVID-19 vaccine encoding a prefusion stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses
R. Bos, L. Rutten, J. E. M. van der Lubbe…·H. Schuitemaker
This paper evaluates a prefusion-stabilized SARS-CoV-2 Spike protein vaccine candidate, Ad26.COV2.S, showing potent neutralizing and Th1-polarized immune responses in mice.
DOI 10.1038/s41541-020-00243-x